Acquire the license to the best health content in the world
Contact Us

March 2011 Briefing - Allergy

Here are what the editors at HealthDay consider to be the most important developments in Allergy for March 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Online Health Records Less Used by Minorities, Poor

WEDNESDAY, March 30 (HealthDay News) -- Online personal health records (PHRs) are less frequently used by racial or ethnic minorities and patients with low annual income, according to a study published in the March 28 issue of the Archives of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Basophil Infiltration Into Skin Lesions Common

WEDNESDAY, March 30 (HealthDay News) -- Immunohistochemical analysis reveals that basophils infiltrate into skin lesions in numerous skin diseases, according to a study published online March 4 in Allergy.

Abstract
Full Text (subscription or payment may be required)

Maternal Anemia Associated With Childhood Wheezing

THURSDAY, March 24 (HealthDay News) -- Maternal anemia during pregnancy is linked with wheezing and asthma in early childhood, according to a study published in the February issue of the Annals of Allergy, Asthma & Immunology.

Abstract
Full Text (subscription or payment may be required)

Reduced Hours for Trainees Has Had Little Effect in U.S.

THURSDAY, March 24 (HealthDay News) -- Reducing work hours for doctors in training to less than 80 per week has had little impact on patient outcomes or postgraduate training in the United States, according to a literature review published online March 22 in BMJ.

Abstract
Full Text
Editorial

Suppressive Therapy Manages Clopidogrel Hypersensitivity

MONDAY, March 21 (HealthDay News) -- Clopidogrel hypersensitivity, which affects up to 6 percent of patients, may be successfully managed using corticosteroids and antihistamines, without interrupting drug therapy, according to a study published in the March 15 issue of The American Journal of Cardiology.

Abstract
Full Text (subscription or payment may be required)

Majority of Parents Approve of Smoke Exposure Testing

MONDAY, March 21 (HealthDay News) -- The majority of parents, both smokers and nonsmokers, want their children tested for tobacco-smoke exposure as part of their children's health care settings, according to a study published online March 21 in Pediatrics.

Abstract
Full Text (subscription or payment may be required)

Professional Values of U.S. and U.K. Doctors Examined

THURSDAY, March 17 (HealthDay News) -- A core of professional values exists among doctors in the United States and the United Kingdom, though significant differences exist in how these values are expressed and prioritized, according to a study published online March 7 in BMJ Quality & Safety.

Abstract
Full Text (subscription or payment may be required)

Adding Omalizumab Improves Asthma Control in Youth

WEDNESDAY, March 16 (HealthDay News) -- The addition of omalizumab to a regimen of guidelines-based therapy among youth with persistent asthma appears to improve asthma control and reduce the need for other medications to control the condition, according to a study published in the March 17 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

Heavy Smoking Prevalence Decline Greatest in California

TUESDAY, March 15 (HealthDay News) -- Between 1965 and 2007, the prevalence of high-intensity smoking declined in California and in the remaining states, according to a study published in the March 16 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Majority of Drugs Tolerated After Negative Re-Challenge

MONDAY, March 14 (HealthDay News) -- Patients who suffer from cutaneous adverse drug reactions (CADR) and have a negative re-challenge under hospital surveillance (RCH) show good tolerance when re-challenged with the same drug, according to a study published online Feb. 9 in Allergy.

Abstract
Full Text (subscription or payment may be required)

Ethnic Differences Seen in Academic Measures for U.K. Docs

WEDNESDAY, March 9 (HealthDay News) -- United Kingdom-trained physicians and medical students with ethnic minority backgrounds tend to underperform academically compared to their white peers, according to a meta-analysis published online March 8 in BMJ.

Abstract
Full Text
Editorial

Pharmacological Meta-Analyses Rarely Report Disclosures

TUESDAY, March 8 (HealthDay News) -- Meta-analyses of pharmacological treatments rarely include information addressing primary study funding and conflicts of interest (COIs) of the authors for the included randomized control trials (RCTs), according to a study published in the March 9 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Inhaled Epinephrine Gives Temporary Relief From Croup

MONDAY, March 7 (HealthDay News) -- Inhaled epinephrine improves moderate to severe croup symptoms in children from 30 minutes to two hours after treatment, according to a literature review published in the Cochrane Database of Systematic Reviews.

Abstract
Full Text (subscription or payment may be required)

FDA Cracking Down on Unapproved Prescription Drugs

WEDNESDAY, March 2 (HealthDay News) -- The U.S. Food and Drug Administration intends to remove select unapproved prescription cough, cold, and allergy medications from the U.S. market, the agency has announced.

More Information

Oral Steroid Therapy Improves Chronic Rhinosinusitis Symptoms

TUESDAY, March 1 (HealthDay News) -- Treatment of chronic rhinosinusitis (CRS) and nasal polyposis with oral steroids followed by topical steroids is more effective than topical steroids alone, according to a study in the March 1 issue of the Annals of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Physician's Briefing